TAVR: Lessons Learned Podcast Available
One day after the final TAVR National Coverage Determination was released, STS hosted a session at the AATS 92nd Annual Meeting that examined the process of TAVR therapy introduction into the United States. The podcast of this session focuses on the parallel review pilot program for medical devices, and how this process reduced time between FDA approval and Medicare coverage for TAVR. Speakers include STS President Jeffrey B. Rich, MD, AATS President Craig R. Smith, MD, ACC Immediate Past President David R. Holmes, MD, as well as representatives for the FDA, CMS, and Edwards Lifesciences.